Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
Tural C, Solà R, Alvarez NP, Moltó J, Sánchez M, Zamora AM, Ornelas A, Laguno M, González J, von Wichmann MÁ, Téllez MJ, Paredes R, Clotet B; CORAL-2 study group. Tural C, et al. Among authors: laguno m. Antivir Ther. 2011;16(6):833-41. doi: 10.3851/IMP1837. Antivir Ther. 2011. PMID: 21900715 Clinical Trial.
Reply to: "Do we promote pre-exposition prophylaxis in the emergency service?".
Laguno M, Ugarte A, Martinez-Rebollar M, de Lazzari E, Mallolas J. Laguno M, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Aug-Sep;41(7):449-450. doi: 10.1016/j.eimce.2023.05.004. Epub 2023 May 27. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 37248156 No abstract available.
Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin.
Laguno M, Larrousse M, Murillas J, Blanco JL, León A, Milinkovic A, Loncá M, Martinez E, Sánchez-Tapias JM, de Lazzari E, Gatell JM, Costa J, Mallolas J. Laguno M, et al. J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):174-8. doi: 10.1097/QAI.0b013e31802b812d. J Acquir Immune Defic Syndr. 2007. PMID: 17106276 Clinical Trial.
Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients.
Laguno M, Larrousse M, Blanco JL, Leon A, Milinkovic A, Martínez-Rebozler M, Loncá M, Martinez E, Sanchez-Tapias JM, de Lazzari E, Gatell JM, Costa J, Mallolas J. Laguno M, et al. AIDS Res Hum Retroviruses. 2008 Apr;24(4):547-53. doi: 10.1089/aid.2007.9994. AIDS Res Hum Retroviruses. 2008. PMID: 18393687
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.
Laguno M, Cifuentes C, Murillas J, Veloso S, Larrousse M, Payeras A, Bonet L, Vidal F, Milinkovic A, Bassa A, Villalonga C, Pérez I, Tural C, Martínez-Rebollar M, Calvo M, Blanco JL, Martínez E, Sánchez-Tapias JM, Gatell JM, Mallolas J. Laguno M, et al. Hepatology. 2009 Jan;49(1):22-31. doi: 10.1002/hep.22598. Hepatology. 2009. PMID: 19085908 Clinical Trial.
154 results